In Response
- PMID: 34032673
- DOI: 10.1213/ANE.0000000000005492
In Response
Conflict of interest statement
Conflicts of Interest: A. Shander has been a consultant for Masimo Corp, Vifor, Octapharma, CSL Bhering, HBO2 therapeutics, Daiichi, Grifols, and Baxter and a speaker for Merck.
Comment on
-
Potential Role of Reticulocyte Hemoglobin in Facilitating Patient Blood Management.Anesth Analg. 2021 Jun 1;132(6):e108-e109. doi: 10.1213/ANE.0000000000005491. Anesth Analg. 2021. PMID: 34032672 No abstract available.
References
-
- Hönemann C, Doll D, Luedi MM, Zimmermann M. Potential role of reticulocyte hemoglobin in facilitating patient blood management. Anesth Analg. 2021;132:e108–e109.
-
- Shander A, Goobie SM, Warner MA, et al.; International Foundation of Patient Blood Management (IFPBM) and Society for the Advancement of Blood Management (SABM) Work GroupEssential role of patient blood management in a pandemic: a call for action. Anesth Analg. 2020;131:74–85.
-
- Warner MA, Shore-Lesserson L, Shander A, Patel SY, Perelman SI, Guinn NR. Perioperative anemia: prevention, diagnosis, and management throughout the spectrum of perioperative care. Anesth Analg. 2020;130:1364–1380.
-
- Muñoz M, Acheson AG, Bisbe E, et al. An international consensus statement on the management of postoperative anaemia after major surgical procedures. Anaesthesia. 2018;73:1418–1431.
-
- Ogawa C, Tsuchiya K, Maeda K. Reticulocyte hemoglobin content. Clin Chim Acta. 2020;504:138–145.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
